期刊文献+

2型糖尿病并发骨质疏松患者血清成骨因子和成脂因子的变化 被引量:1

Changes of serum osteogenic and adipogenic factors in type 2 diabetic patients with osteoporosis
下载PDF
导出
摘要 目的:探讨血清成骨因子和成脂因子在2型糖尿病并发骨质疏松患者中的变化规律。方法:选择2016年4月—2017年10月盐城市第一人民医院进行双能X线骨密度(dual energy X-ray absorptiometry, DXA)检查的120例2型糖尿病患者为观察组(A组:骨密度正常的患者30例,B组:合并骨量减少的患者28例,C组:合并骨质疏松的患者33例,D组:合并骨质疏松并行强化血糖控制的患者29例),30例非糖尿病且骨密度正常的健康者为对照组,应用酶联免疫吸附法测定研究对象的碱性磷酸酶(alkaline phosphatase, ALP)、Runt相关转录因子2(Runt-related transcription factor 2,Runx2)、过氧化物酶增殖物激活受体γ(peroxisome proliferator-activated receptorγ, PPARγ)、CCAAT-增强子结合蛋白α(CCAAT/enhancer binding proteinα, C/EBPα)水平。结果:观察组各亚组糖化血红蛋白均高于对照组(P<0.05),DXA骨密度测定T值均低于对照组(P<0.05);观察组中D组糖化血红蛋白低于C组(P<0.05),DXA骨密度测定T值高于C组(P<0.05);观察组各亚组的ALP、Runx2水平均明显低于对照组(P<0.05),PPARγ、C/EBPα水平均高于对照组(P<0.05);观察组中D组患者ALP、Runx2水平高于C组(P<0.05),PPARγ、C/EBPα水平低于C组(P<0.05)。ALP、Runx2与骨密度水平呈正相关,PPARγ、C/EBPα水平与骨密度水平呈负相关。结论:血清成骨因子和成脂因子在2型糖尿病并发骨质疏松形成及发展过程中具有重要意义,骨密度水平与成骨因子呈正相关,与成脂因子呈负相关,可为骨质疏松诊断及治疗效果评估提供参考,以提高诊断准确性。 Objective:To investigate the change rules of serum osteogenic factor and adipogenic factor in type 2 diabetes mellitus with osteoporosis.Methods:From April 2016 to October 2017,a total of 120 patients with type 2 diabetes mellitus were measured bone mineral density by using dual energy X-ray absorptiometry(DXA)in the Yancheng City No.1 People′s Hospital.They were selected as the observation group(Group A:30 patients with normal bone mineral density,Group B:28 patients with bone mass loss,Group C:33 patients with osteoporosis,Group D:29 patients with osteoporosis and intensive blood glucose control).Thirty healthy patients with normal bone mineral density were selected as the control group.The levels of alkaline phosphatase(ALP),Runt-related transcription factor 2(Runx2),peroxisome proliferator-activated receptorγ(PPARγ)and CCAAT/enhancer binding proteinα(C/EBPα)were detected by enzyme-linked immunosorbent assay(ELISA).Results:The level of HbA1c in all observation groups was significantly higher than that in the control group(P<0.05),and the T-score measured by DXA in all observation groups was significantly lower compared to the control group(P<0.05).In the observation groups,the level of HbA1c in Group D was significantly lower than that in Group C(P<0.05),and the T-score measured by DXA in Group D was significantly higher than that in Group C(P<0.05).The levels of ALP and Runx2 in all observation groups were significantly lower than those in the control group(P<0.05),and the levels of PPARγand C/EBPαin the observation group were significantly higher than those in the control group(P<0.05).In the observation groups,the levels of ALP and Runx2 in Group D were significantly higher than those in Group C(P<0.05),and the levels of PPARγand C/EBPαin Group D were significantly lower than those in Group C(P<0.05).The levels of ALP and Runx2 are positively correlated with the bone mineral density.And the levels of PPARγand C/EBPαare negatively correlated with the bone mineral density.Conclusions:The levels of
作者 王春雷 胥柯 蒯凤 孙清林 黄飞 刘艳梅 WANG Chunlei;XU Ke;KUAI Feng;SUN Qinglin;HUANG Fei;LIU Yanmei(Department of Endocrinology,the Fourth Affiliated Hospital of Nantong University,Yancheng City No.1 People′s Hospital,Jiangsu Province,Yancheng 224001)
出处 《南通大学学报(医学版)》 2018年第4期252-255,共4页 Journal of Nantong University(Medical sciences)
基金 盐城市科技计划项目(YK2016012)
关键词 2型糖尿病 骨质疏松 成骨因子 成脂因子 type 2 diabetes mellitus osteoporosis osteogenic factor adipogenic factor
  • 相关文献

参考文献13

二级参考文献86

  • 1宫明智,唐立群,刘中浩,邢德国,武士清,张建平.糖尿病模型大鼠骨折后骨痂细胞增殖情况的观察[J].中华老年医学杂志,2006,25(10):772-774. 被引量:3
  • 2刘珺,王维,童琼娟,刘煌辉,欧阳彬.双能X线骨密度仪(DXA)与定量CT(QCT)测量骨密度的比较研究[J].临床放射学杂志,2007,26(5):504-507. 被引量:30
  • 3叶任高 主编.内科学:第五版[M].北京:人民卫生出版社,2001.92—94. 被引量:23
  • 4Miyata T, Notoya K, Yoshida K, et al. Advanced glycation end products enhance osteoclast- inducedbone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously withdevitalized bone particles. J Am Soc Nephrol 1997;8(2) :260 - 270. 被引量:1
  • 5Chung YS, Lee MD, Lee SK, et al. HMG - CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients. J Clin Endocrinol Metab 2000;85(3) :1137- 1142. 被引量:1
  • 6Liu EY,Wactawski-Wende J,Donahue RP,et al.Does low bone mineral density start in post-teenage years in women with type 1 diabetes?[J].Diabetes Care,2003,26(8):2365-2369. 被引量:1
  • 7Kemink SA,Hermus AR,Swinkels LM,et al.Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology[J].J Endocrinol Invest,2000,23(5):295-303. 被引量:1
  • 8Schwartz AV,Sellmeyer DE,Strotmeyer ES,et al.Diabetes and bone loss at the hip in older black and white adults[J].J Bone Miner Res,2005,20(4):596-603. 被引量:1
  • 9Santana RB,Xu L,Chase HB,et al.A role for advanced glycation end products in diminished bone healing in type 1 diabetes[J].Diabetes,2003,52(6):1502-1510. 被引量:1
  • 10Yamagishi S,Nakamura K,Inoue H.Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients[J].Med Hypotheses,2005,65(6):1013-1015. 被引量:1

共引文献259

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部